Life Stem Genetics Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a LIFS research report →
Companywww.lifestemgenetics.com
Life Stem Genetics Inc. , a development stage company, focuses on establishing stem cell therapy based clinics worldwide. Its products and services include nutraceutical and medical supplements, and IV nutritional cocktails; stem cell banking services; stem cell treatments for degenerative conditions, hyperbaric oxygen therapy, cancer treatments, and weight loss; anti-aging stem cell therapy; anti-viral therapy; and adistem stem cell treatments for orthopedics, neurological, and lung diseases.
- CEO
- Gloria Simov
- IPO
- 2013
- HQ
- East Stroudsburg, NV, US
Price Chart
Valuation
- Market Cap
- $4.58K
- P/E
- -2.38
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- -0.44
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 0.00%
- ROIC
- 0.00%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-10,572 · 74.08%
- EPS
- $0.00 · 100.00%
- Op Income
- $-10,540
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.00
- Avg Volume
- 562
Get TickerSpark's AI analysis on LIFS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our LIFS Coverage
We haven't published any research on LIFS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate LIFS Report →